Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Clinical Evaluation of the TVA FLEX-1 Device Protocol Flex-1-002-IR Intervention Reduction

NCT02119832 is registered in ClinicalTrials.gov with C. R. Bard as lead sponsor.

NCT NCT02119832
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02119832 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Clinical Evaluation of the TVA FLEX-1 Device Protocol Flex-1-002-IR Intervention Reduction
Lead sponsor
C. R. Bard
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2013
Completion date
February 28, 2014
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease (ckd)